≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm of other and unspecified intrathoracic organs

DOID Endpoint Browser PheWeb

CD2_BENIGN_INTRATHORACIC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D15
  • Cause of death: ICD-10 — D15

2 out of 7 registries used, show all original rules.

328

4. Check minimum number of events

None

328

5. Include endpoints

381

6. Filter based on genotype QC (FinnGen only)

381

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10-D36
Name in latin
Neoplasmata benigna organorum endothoracicorum aliorum sive non specificatorum

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2498 1388 1085
Only index persons 2049 1198 851
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.03
Only index persons 0.04 0.04 0.03
Median age at first event (years)
Whole population 54.47 56.23 51.98
Only index persons 52.89 55.50 49.23

-FinnGen-

Key figures

All Female Male
Number of individuals 381 208 173
Unadjusted period prevalence (%) 0.07 0.07 0.08
Median age at first event (years) 56.40 55.68 57.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
340
Matched controls
3398
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D15.1
ICD-10 Finland
Benign neoplasm: Heart
+∞
115.3
104
*
D15.2
ICD-10 Finland
Benign neoplasm: Mediastinum
+∞
82.8
76
*
FFA10
NOMESCO Finland
Excision of lesion of atrium
+∞
66.9
62
*
D15.0
ICD-10 Finland
Benign neoplasm: Thymus
+∞
64.7
60
*
D15.9
ICD-10 Finland
Benign neoplasm: Intrathoracic organ, unspecified
+∞
41.5
39
*
D15.7
ICD-10 Finland
Benign neoplasm: Other specified intrathoracic organs
+∞
35.0
33
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
73.1
34.8
39
6
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
182.1
32.3
33
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.8
31.9
88
166
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
8.0
26.5
63
94
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
26.0
110
332
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
25.0
208
1085
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
+∞
23.2
22
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
8.9
20.8
45
57
21250
ICD-8 Finland
Benign neoplasm of respiratory system, Mediastinum
+∞
20.0
19
*
GEC23
NOMESCO Finland
Transsternal thymectomy
200.6
18.7
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
18.1
135
609
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
+∞
17.9
17
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.2
14.3
45
96
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
44.5
14.2
17
*
AJX
HP
Other surgery on the heart or aorta
+∞
13.6
13
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
13.3
88
356
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
72.6
12.7
14
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.7
12.4
99
447
R4110
NOMESCO Finland
Physiotherapy
2.5
11.9
118
601
8580/3-C37.9
ICD-O-3
Thymoma, NOS, of thymus
+∞
11.5
11
*
WX872
NOMESCO Finland
Intensive care
4.7
11.4
39
91
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
10.9
91
420
C37
ICD-10 Finland
Malignant neoplasm of thymus
113.4
10.5
11
*
AMX
HP
Other surgical procedure for a demanding cardiac patient
+∞
10.5
10
*
2125A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Mediastinum
+∞
10.5
10
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
9.9
44
132
GAE06
NOMESCO Finland
Excision of lesion of chest wall
102.8
9.5
10
*
8582/3-C37.9
ICD-O-3
Thymoma, type AB of thymus
+∞
9.4
9
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
9.2
35
92
WZC30
NOMESCO Finland
Teaching
2.8
9.1
63
259
B01AB05
ATC
enoxaparin; parenteral
2.1
8.5
122
715
N07AA02
ATC
pyridostigmine; systemic
22.7
8.1
11
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
8.1
85
435
C03CA01
ATC
furosemide; systemic
2.1
8.0
112
647
G70.0
ICD-10 Finland
Myasthenia gravis
18.9
7.6
11
6
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
7.4
38
128
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
+∞
7.3
7
*
WX402
NOMESCO Finland
General anaesthesia
2.4
7.0
64
304
108
Kela drug reimbursment
Myasthenia gravis
23.0
6.7
9
*
51
HP
Other heart surgery
71.1
6.4
7
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.2
6.4
16
27
AN1
HP
Coronary angiography
2.5
6.4
48
207
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
9.5
6.3
12
13
ZXC96
NOMESCO Finland
Robot assisted procedure
5.0
6.3
19
40
2129X
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Site unspecified
+∞
6.3
6
*
GAA31
NOMESCO Finland
Thoracoscopy
27.2
6.3
8
*
GEA00
NOMESCO Finland
Mediastinoscopy
27.2
6.3
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
6.2
104
635
TFP20
NOMESCO Finland
Cardiodefibrillation
3.2
6.2
31
104
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.1
147
1017
XF404
NOMESCO Finland
Ambulatory ECG
2.7
6.0
39
154

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
243
1312
3.35
28.63
8.7
8.4
inr
1.2
1.2
0.02
48
379
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
159
767
2.84
21.20
2.3
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
250
1564
2.74
19.34
8.4
6.7
mmol/l
1.2
1.2
2.37
222
1336
(3044640) Blood type and Crossmatch panel - Blood
186
1014
2.63
18.97
2.5
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
237
1471
2.62
18.18
3.8
4.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
231
1429
2.57
17.65
9.9
5.8
mmol/l
1.2
1.2
2.14
220
1292
(3016502) Oxygen saturation in Arterial blood
86
338
2.99
16.23
11.2
7.5
%
96.0
95.7
0.15
86
325
(3002173) Hemoglobin [Mass/volume] in Arterial blood
81
308
3.07
16.19
11.2
7.8
g/l
118.5
120.7
0.43
81
300
(3003396) Base excess in Arterial blood by calculation
89
373
2.81
14.83
11.0
7.1
mmol/l
1.4
1.0
0.41
79
294
(3027801) Oxygen [Partial pressure] in Arterial blood
89
376
2.78
14.58
11.0
7.0
kpa
12.6
12.1
0.48
89
359
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
89
376
2.78
14.58
11.0
7.0
kpa
5.4
5.1
2.34
89
358
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
53
165
3.57
14.58
11.5
8.8
—
—
—
0
0
(4035726)
76
301
2.90
14.01
1.4
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
60
209
3.22
13.81
12.8
8.6
%
0.7
0.7
0.16
60
204
(3000991) Gas panel - Venous blood
69
267
2.93
13.23
10.7
8.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
59
210
3.14
13.08
12.7
8.5
%
1.2
1.5
1.31
59
205
(3013826) Glucose [Moles/volume] in Serum or Plasma
263
1865
2.32
12.93
7.9
4.6
mmol/l
6.6
6.7
0.28
252
1741
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
314
2439
2.63
12.08
9.2
7.6
u/l
80.9
78.6
0.51
303
2282
(42870588) Differential panel, method unspecified - Blood
170
1038
2.15
11.84
6.8
5.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
159
958
2.13
11.35
4.7
3.9
ph
7.4
7.4
0.73
26
175
(3023368) Bacteria identified in Blood by Culture
146
854
2.15
11.23
4.8
4.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
133
761
2.15
10.74
2.9
2.0
mg/l
3.3
3.2
0.11
116
654
(3024561) Albumin [Mass/volume] in Serum or Plasma
200
1350
2.01
10.16
5.6
4.8
g/l
35.5
35.6
0.03
183
1271
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
155
956
2.05
10.13
3.7
3.3
ng/l
885.3
1328.0
1.85
140
797
(3002030) Lymphocytes/100 leukocytes in Blood
212
1479
1.98
9.60
7.2
5.9
%
26.0
27.7
1.53
203
1377
(3019069) Monocytes/100 leukocytes in Blood
209
1452
1.97
9.57
7.4
6.1
%
8.8
8.7
0.26
201
1367
(3006504) Eosinophils/100 leukocytes in Blood
206
1445
1.93
8.96
7.1
5.8
%
2.6
2.9
1.07
195
1348
(3019198) Lymphocytes [#/volume] in Blood
220
1581
1.93
8.85
6.9
5.7
e9/l
1.7
2.0
1.56
187
1392
(3018010) Neutrophils/100 leukocytes in Blood
206
1457
1.90
8.61
7.0
5.7
%
59.5
57.1
2.35
199
1367
(3001604) Monocytes [#/volume] in Blood
216
1552
1.90
8.60
6.9
5.6
e9/l
0.6
0.6
0.30
178
1341
(3022096) Basophils/100 leukocytes in Blood
200
1403
1.90
8.56
7.2
5.8
%
0.7
0.7
0.12
192
1310
(3013115) Eosinophils [#/volume] in Blood
221
1603
1.90
8.51
7.5
6.0
e9/l
0.2
0.2
2.13
185
1404
(3006315) Basophils [#/volume] in Blood
215
1556
1.88
8.23
6.9
5.7
e9/l
0.0
0.0
0.39
178
1345
(3013650) Neutrophils [#/volume] in Blood by Automated count
241
1810
1.90
8.20
10.9
9.5
e9/l
4.1
4.1
0.14
200
1592
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
85
3.48
7.96
4.5
2.3
u/ml
0.3
0.3
0.00
19
45
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
149
969
1.88
7.91
2.4
2.1
u/l
198.9
215.9
0.21
144
907
(3002256) Pathology report gross observation
78
411
2.13
7.50
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
105
620
1.96
7.38
4.0
3.9
ng/l
365.4
301.5
0.13
89
493
(40768804) Tissue Pathology biopsy report
179
1260
1.79
7.17
2.2
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
181
1287
1.77
6.93
3.3
2.7
ug/l
137.6
131.3
0.12
168
1176
(3013707) Erythrocyte sedimentation rate by Westergren method
285
2320
1.91
6.89
5.1
4.1
mm/h
15.1
12.0
1.98
269
2126
(3019060) Gas panel - Arterial blood
48
218
2.38
6.56
8.5
4.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
120
785
1.77
5.93
7.9
7.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
58
299
2.11
5.84
5.1
3.8
mmol/l
2.5
2.0
0.46
46
238
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
218
1684
1.69
5.83
7.9
6.4
umol/l
11.4
11.3
0.08
206
1597
(4010399)
49
237
2.23
5.79
1.4
1.4
—
—
—
0
0
(3012544) pH of Venous blood
59
308
2.08
5.75
5.1
3.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
44
205
2.30
5.67
15.4
7.0
mmol/l
26.1
24.2
2.63
44
192
(3015377) Calcium [Moles/volume] in Serum or Plasma
150
1056
1.69
5.65
3.8
3.5
mmol/l
2.3
2.4
0.29
133
929
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
83
492
1.88
5.63
2.3
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
74
424
1.92
5.56
3.0
2.4
%
19.2
23.0
1.95
67
366
(3018095) Leukocytes [#/volume] in Urine
155
1117
1.65
5.25
4.0
3.6
e6/l
133.4
89.2
0.23
111
805
(3044889) 12 lead EKG panel
268
2219
1.70
5.23
5.0
3.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
40
3.86
5.14
2.7
2.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
183
1384
1.62
5.06
12.6
9.4
e9/l
0.0
0.0
0.04
143
1134
(3037467) Urinalysis macro (dipstick) panel - Urine
259
2139
1.66
4.96
4.6
4.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
174
2.25
4.68
1.8
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
126
889
1.62
4.51
3.6
3.0
e6/l
0.4
0.5
0.22
94
667
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
102
2.55
4.31
3.0
2.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
40
201
2.11
4.31
2.1
1.6
g/l
0.9
1.3
1.26
32
184
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
101
682
1.65
4.28
2.5
1.7
mg/l
1.2
1.2
0.05
86
539
(3005719) IgG [Mass/volume] in Serum or Plasma
47
252
1.99
4.26
3.4
2.8
g/l
10.5
10.3
0.06
42
233
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
46
3.35
4.23
1.2
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
166
1266
1.55
4.20
2.6
2.3
nmol/l
78.7
78.1
0.10
150
1109
(40760888) Immunoglobulin light chains.free panel - Serum
19
68
2.89
4.18
2.9
5.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
133
968
1.57
4.12
3.7
3.1
e6/l
22.0
125.3
0.90
100
749
(36304419) Bacteria [Presence] in Urine
120
854
1.59
4.09
3.7
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
79
506
1.71
4.06
2.9
2.9
e6/l
4.0
1.9
0.73
40
283
(3026008) Bacteria identified in Urine by Culture
129
938
1.57
3.99
3.7
3.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
187
2.08
3.94
2.0
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
8
8.89
3.78
1.9
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
5
12.16
3.77
13.8
8.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
5
12.16
3.77
11.7
8.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
356
1.78
3.73
2.2
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
151
1152
1.51
3.70
3.9
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
161
1245
1.51
3.70
5.2
3.8
ng/l
47.5
37.6
0.45
114
891
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
339
3092
1.87
3.68
22.9
14.3
mg/l
23.4
23.1
0.07
310
2445
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
22
92
2.48
3.63
2.0
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
447
1.69
3.63
1.6
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
39
210
1.95
3.51
2.4
2.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
38
205
1.95
3.40
4.1
3.9
kpa
5.5
5.1
1.42
32
189
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
53
2.91
3.39
1.5
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
21
89
2.44
3.38
5.4
2.3
%
91.3
90.2
0.07
21
84
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
80
540
1.61
3.33
2.9
2.7
e6/l
1.1
1.0
0.17
43
315
(3000492) Spirometry study
50
297
1.79
3.33
1.5
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
361
1.72
3.29
2.3
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
91
636
1.57
3.27
2.9
2.8
mosm/kgh2o
543.3
553.5
0.18
77
539
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
315
2843
1.62
3.20
4.8
4.6
mu/l
1.9
1.9
0.01
294
2568
(3023520) Reticulocytes [#/volume] in Blood
47
279
1.78
3.14
2.9
2.7
e9/l
80.3
69.1
1.01
27
220
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
74
2.50
3.09
2.0
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
68
2.57
3.08
2.2
2.3
g/l
128.6
128.0
—
8
47
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
191
1.92
3.05
4.2
4.0
mmol/l
2.9
1.8
1.06
29
148
(3043409) Potassium [Moles/volume] in Arterial blood
23
107
2.22
3.03
10.8
3.9
mmol/l
3.9
4.0
0.43
23
96
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
21
95
2.28
2.95
3.2
4.6
—
2.6
—
0
10
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
35
3.21
2.95
1.8
1.6
ug/l
23.5
18.2
0.19
11
35
(3018405) Lactate [Moles/volume] in Arterial blood
26
129
2.09
2.94
9.9
3.5
mmol/l
1.3
1.4
0.40
26
121
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
159
1270
1.43
2.92
2.0
1.9
pmol/l
92.6
96.7
0.53
92
647
(3000850) Epithelial cells [#/volume] in Urine
93
669
1.52
2.92
3.1
2.5
e6/l
4.0
4.9
0.75
83
590
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
131
2.06
2.83
2.4
2.1
g/l
7.7
7.4
0.32
21
95
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
131
2.06
2.83
2.4
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
131
2.06
2.83
2.4
2.1
g/l
3.5
3.8
0.51
21
90
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
21
97
2.23
2.82
3.2
4.6
mg/l
20.9
35.3
1.61
16
80
(3034860) Kappa light chains.free [Mass/volume] in Serum
21
97
2.23
2.82
3.2
4.5
mg/l
179.2
118.7
0.24
15
79
(3021901) Oxygen saturation in Capillary blood
14
53
2.70
2.82
3.7
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
66
2.49
2.74
3.1
2.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
54
2.65
2.73
4.4
3.3
%
59.0
57.3
0.17
14
54
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
37
3.03
2.71
5.5
2.9
nmol/l
3.0
8.0
0.61
11
37
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
19
4.28
2.69
4.5
3.5
nmol/l
91.4
94.6
—
8
19
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
223
1.78
2.66
1.6
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
20
4.06
2.58
1.5
2.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
25
129
2.00
2.57
2.0
1.9
g/l
1.8
1.4
0.79
19
112
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
591
1.49
2.53
3.0
3.0
mmol/l
2.5
2.5
0.51
71
520
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
314
1.64
2.51
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
63
2.44
2.49
4.5
3.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
51
2.60
2.47
1.2
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
51
2.60
2.47
4.6
2.9
e9/l
4.2
4.7
0.39
13
51
(3039000) Anion gap in Blood
16
70
2.34
2.44
8.9
6.6
mmol/l
10.2
11.0
0.53
16
64
(3018572) Chloride [Moles/volume] in Blood
16
70
2.34
2.44
8.9
6.6
mmol/l
106.2
104.9
0.59
16
64
(3026493) Urate [Moles/volume] in Serum or Plasma
107
821
1.42
2.38
3.3
2.8
umol/l
339.0
6867.4
3.31
99
714
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
8
6.31
2.38
3.2
8.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
55
368
1.58
2.38
3.1
4.2
ug/l
4.2
45.3
1.17
42
311
(3022313) Gas panel - Capillary blood
27
148
1.89
2.35
4.1
3.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
60
414
1.53
2.27
35.3
20.7
inr
1.4
1.3
—
7
55
(3037522) Nuclear Ab [Titer] in Serum
60
415
1.53
2.25
1.5
1.3
titre
368.4
508.8
0.57
19
93
(3042631) Mycobacterium sp identified in Specimen
10
36
2.83
2.22
3.1
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
84
625
1.44
2.20
1.7
1.5
g/l
2.5
2.5
0.01
51
376
(3037121) Protein [Mass/volume] in Urine
20
101
2.03
2.20
2.7
3.3
g/l
0.3
0.2
—
10
41
(3020564) Creatinine [Moles/volume] in Serum or Plasma
349
3297
1.70
2.19
25.8
17.0
umol/l
78.7
77.2
0.32
349
3297
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
95
2.05
2.14
1.5
1.4
ug/g
252.2
306.0
0.45
13
57
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
62
2.31
2.10
1.6
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
210
1826
1.33
2.06
3.0
2.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
103
804
1.39
2.05
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
73
536
1.45
2.05
1.2
1.3
iu/ml
114.8
40.1
0.77
20
171
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
350
3318
1.67
2.04
13.7
10.6
u/l
24.9
26.1
0.97
344
3195
(3005322) IgE [Units/volume] in Serum or Plasma
31
187
1.72
2.01
1.4
1.2
u/ml
109.7
198.7
0.72
25
167
(3011397) Hemoglobin [Presence] in Urine by Test strip
92
708
1.39
1.99
3.7
3.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
52
359
1.52
1.97
3.1
2.9
umol/l
7.9
9.5
0.21
44
318
(3037756) Immunofixation for Serum or Plasma
14
64
2.23
1.97
1.4
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
61
436
1.48
1.96
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
44
293
1.57
1.96
2.5
2.5
u/l
34.6
31.8
0.29
37
245
(3007853) Bacteria identified in Skin by Aerobe culture
50
343
1.53
1.95
1.9
1.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
8
27
3.00
1.94
1.8
1.2
u/l
227.0
279.7
—
8
27
(3020891) Body temperature
23
128
1.85
1.94
15.3
4.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
33
2.77
1.94
1.1
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
107
1.92
1.90
1.4
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
63
457
1.45
1.88
2.2
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
122
1.85
1.88
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
56
397
1.48
1.88
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
52
363
1.50
1.88
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
34
2.69
1.87
2.1
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
34
2.69
1.87
2.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
34
2.69
1.87
1.7
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
12
4.21
1.83
1.6
1.8
ug/l
56.4
61.8
—
5
12
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
23
3.08
1.80
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
41
2.48
1.77
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
94
740
1.36
1.76
1.7
1.5
nmol/l
19.4
21.1
0.68
87
623
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
36
2.54
1.75
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
36
2.54
1.75
2.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
103
1.89
1.75
2.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
61
2.17
1.73
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
61
2.17
1.73
1.2
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
257
2336
1.31
1.67
3.8
3.9
pmol/l
14.9
14.9
0.08
236
2090
(3000475) Leukocytes [#/volume] in Synovial fluid
15
77
1.99
1.61
1.7
1.5
e6/l
28248.1
20140.7
—
9
55
(3044927) Protein electrophoresis panel - Urine
8
32
2.53
1.60
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
26
2.72
1.58
2.4
2.0
e6/l
595.3
507.8
—
7
20
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
226
2028
1.28
1.58
3.9
3.2
u/l
52.1
50.0
0.10
217
1890
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
312
2925
1.37
1.56
19.7
13.4
ml/min/173m2
80.9
79.8
0.40
279
2408
(3019230) Fractional oxyhemoglobin in Venous blood
12
57
2.14
1.56
1.8
1.8
%
73.5
63.4
0.82
12
57
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
100
1.84
1.56
1.2
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
72
1.98
1.50
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
66
504
1.37
1.50
1.2
1.3
u/ml
14.7
11.8
0.12
20
200
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
37
2.47
1.49
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
196
1.58
1.48
1.1
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
38
2.40
1.46
2.1
1.2
nmol/l
0.7
0.5
—
9
33
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
22
133
1.69
1.46
7.7
4.6
%
1.9
1.5
0.81
22
126
(3007930) Methemoglobin/Hemoglobin.total in Blood
22
133
1.69
1.46
7.7
4.6
%
0.9
0.9
0.06
22
127
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
320
3022
1.37
1.44
4.8
4.7
mmol/l
5.9
6.0
0.26
294
2754
(3035880) pH of Pleural fluid
5
16
3.15
1.44
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
22
2.75
1.44
1.3
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
36
248
1.50
1.41
2.6
2.8
ml/min/173m2
75.7
61.9
1.11
18
101
(3003434) Protein [Mass/volume] in Pleural fluid
9
40
2.28
1.41
2.1
1.4
g/l
36.5
31.4
—
9
35
(3021601) Nitrite [Presence] in Urine by Test strip
174
1532
1.25
1.36
5.0
5.2
estimate
0.0
0.0
0.50
39
291
(3017732) Neutrophils [#/volume] in Blood
31
211
1.51
1.30
3.4
2.3
e9/l
4.4
3.8
0.65
31
162
(4062490)
8
34
2.38
1.30
2.1
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
18
2.80
1.29
15.0
18.3
nmol/l
1518.0
1448.8
—
5
18
(3017704) Immunofixation for Urine
5
18
2.80
1.29
1.2
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
18
2.80
1.29
12.4
13.6
nmol/l
1065.6
863.4
—
5
18
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
55
2.03
1.28
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
36
2.25
1.25
2.8
4.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
19
2.65
1.22
3.4
1.4
g/l
0.8
1.0
—
5
19
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
2.4
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
119
1015
1.25
1.21
2.6
2.4
u/l
55.6
56.9
0.19
105
939
(3005570) Glucose [Moles/volume] in Urine
6
26
2.33
1.19
1.8
2.1
—
—
—
0
0
(4306422)
8
38
2.13
1.19
1.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
174
1549
1.23
1.18
3.9
3.8
estimate
0.0
0.0
0.00
36
282
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
208
1.48
1.17
1.6
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
2.4
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
20
2.52
1.15
1.6
1.3
—
—
—
0
0
(4268621)
7
30
2.36
1.13
2.6
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
307
2911
1.28
1.12
5.6
5.9
mmol/mol
39.1
40.1
1.36
286
2699
(3019309) Folate [Moles/volume] in Red Blood Cells
73
595
1.28
1.08
2.0
1.7
nmol/l
1161.0
1207.1
0.18
57
447
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
42
317
1.37
1.05
3.5
3.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
75
1.76
1.04
2.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
34
2.08
1.03
3.6
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
1.0
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
47
1.94
1.03
1.3
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
53
1.91
1.02
3.8
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
68
1.79
1.01
2.1
1.2
—
1.0
—
0
5
(3044941) Cell count panel - Synovial fluid
9
48
1.90
1.01
1.2
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
169
1520
1.20
0.99
3.9
3.7
estimate
0.0
0.0
0.00
38
291
(40761511) CBC panel - Blood by Automated count
335
3226
1.32
0.98
20.3
13.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
30
0.00
0.97
0.0
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
50
1.82
0.97
2.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
77
1.71
0.96
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
85
1.67
0.95
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
27
2.24
0.94
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
27
2.24
0.94
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
52
1.75
0.93
1.2
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
55
1.84
0.93
1.0
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
78
1.69
0.92
1.3
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
63
1.77
0.91
2.5
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
93
1076
0.82
0.90
3.0
3.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
79
1.67
0.89
2.0
1.3
—
2.9
—
0
15
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
103
1.58
0.89
2.1
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
294
2799
1.22
0.88
24.4
15.5
%
39.3
40.1
1.17
213
1978
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
43
1.88
0.88
1.3
1.1
—
—
—
0
0
(3013512) EKG study
109
952
1.20
0.86
5.1
3.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
80
1.65
0.85
1.8
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
197
1.40
0.85
1.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
2.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
34
1.78
0.76
2.3
1.2
nmol/l
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
53
1.71
0.76
2.7
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
13
83
1.59
0.76
1.5
1.1
—
51.4
—
0
7
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
75
1.62
0.75
1.6
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
2.4
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(4024509)
5
24
2.10
0.75
1.8
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
55
1.65
0.74
2.0
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
40
319
1.28
0.73
1.6
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
35
274
1.31
0.73
4.4
4.3
%
1.5
0.9
—
9
90
(21494755) Public health laboratory ask at order entry panel
20
274
0.71
0.72
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
186
1.37
0.72
1.1
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
109
1.49
0.72
1.7
1.8
—
145.7
—
0
7
(3049717) Cytology report of Urine Cyto stain
18
126
1.45
0.71
1.8
2.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
57
1.59
0.71
1.3
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
5
26
1.94
0.71
1.4
1.2
u/ml
0.1
0.1
—
5
11
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
26
1.94
0.71
1.8
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
26
1.94
0.71
1.8
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
231
1.32
0.70
1.7
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
77
1.58
0.69
1.2
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
59
1.54
0.69
1.4
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
3.8
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
29
224
1.32
0.67
2.2
2.0
nmol/l
15.4
13.5
0.49
20
206
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
13
86
1.53
0.67
2.0
1.3
—
1.2
—
0
5
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
29
1.73
0.64
1.8
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
94
834
1.17
0.63
1.5
1.7
mmol/l
1.3
1.4
0.45
83
701
(3021440) Promyelocytes/100 leukocytes in Blood
32
254
1.28
0.62
4.3
4.4
%
0.4
0.2
—
8
81
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
20
0.00
0.60
0.0
5.9
—
37.6
—
0
5
(4027681)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
97
1.46
0.60
1.0
1.3
—
—
—
0
0
(4281824)
6
35
1.73
0.58
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
239
1.28
0.57
4.7
4.4
%
0.1
0.2
—
7
66
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
36
1.68
0.57
1.8
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
73
1.52
0.57
1.8
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
55
1.46
0.56
1.9
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
37
1.63
0.56
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
99
1.43
0.55
1.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
99
1.43
0.55
1.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
125
1.38
0.54
1.6
1.9
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
38
1.59
0.54
3.7
1.8
%
89.9
89.2
—
6
38
(3009508) Creatinine [Moles/volume] in Urine
110
1000
1.14
0.53
3.3
3.1
mmol/l
8.1
7.5
0.57
102
829
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
39
1.55
0.53
3.3
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
39
1.55
0.53
1.2
1.9
pg
22.3
32.3
—
6
39
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
39
1.55
0.53
1.2
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
351
3442
1.25
0.53
33.3
21.2
e12/l
4.4
4.5
2.26
345
3335
(3010813) Leukocytes [#/volume] in Blood
351
3442
1.25
0.53
33.4
21.2
e9/l
6.8
6.7
0.35
346
3336
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
63
1.44
0.52
2.0
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
99
0.60
0.52
4.2
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
105
953
1.14
0.52
3.3
3.3
mg/l
1189.2
188.8
0.64
74
615
(40768800) Prostate Pathology biopsy report
9
64
1.42
0.52
1.3
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
40
1.51
0.52
1.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
71
629
1.16
0.49
1.8
1.8
pmol/l
406.9
446.9
0.85
60
515
(4034850)
7
109
0.64
0.49
17.9
11.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
244
0.77
0.48
1.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
264
1.23
0.47
5.5
3.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
31
1.62
0.43
1.2
1.2
—
94.4
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
5
32
1.57
0.42
2.6
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
105
1.35
0.41
1.5
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
33
1.52
0.41
1.2
3.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
88
1.38
0.40
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
76
688
1.13
0.40
1.3
1.3
u/ml
0.9
1.4
0.61
21
194
(21494434) Karyotype in Bone marrow
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
606
0.87
0.38
3.0
3.0
ug/l
1.4
0.8
0.94
39
395
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
37
1.36
0.37
2.6
2.8
u/ml
15.3
60.6
—
5
37
(3014051) Protein [Presence] in Urine by Test strip
9
70
1.29
0.37
2.1
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
81
1.37
0.36
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
41
1.47
0.36
1.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
78
0.64
0.36
1.4
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
42
1.44
0.35
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
42
1.44
0.35
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
43
1.40
0.35
23.7
7.5
mmol/l
8.0
6.7
—
6
35
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
43
380
1.15
0.33
2.4
2.2
ug/g
124.8
125.4
0.01
38
315
(3020682) Albumin/Creatinine [Ratio] in Urine
107
1000
1.10
0.32
4.0
4.0
mg/mmol
9.3
8.9
0.02
73
630
(3019225) pH of Specimen
34
296
1.16
0.31
4.2
4.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
175
0.79
0.31
2.9
2.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
231
1.18
0.30
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
239
0.83
0.30
1.5
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
80
862
0.91
0.29
3.9
3.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
113
1198
0.92
0.29
4.8
3.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
85
1.30
0.28
1.5
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
67
1.20
0.26
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
77
1.31
0.26
1.1
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
39
434
0.89
0.26
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
30
264
1.15
0.25
4.6
3.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
73
679
1.09
0.25
6.0
5.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
332
1.13
0.24
1.8
1.8
%
1.5
1.5
0.15
32
295
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
218
1.16
0.24
2.8
2.5
—
12.1
—
0
8
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4198724)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
12
0.00
0.21
0.0
1.3
—
339.9
—
0
7
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
110
1049
1.07
0.21
4.6
4.8
ug/l
2.4
2.7
0.23
100
937
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.1
—
133.1
—
0
13
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.9
—
—
—
0
0
(4094501)
10
80
1.26
0.20
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
79
834
0.93
0.19
3.7
4.4
%
23.1
21.4
0.44
35
405
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
66
0.75
0.17
1.6
1.3
mmol/l
3.9
3.9
—
5
60
(3029937) Albumin [Presence] in Urine by Test strip
87
831
1.06
0.16
5.0
3.9
estimate
0.0
0.0
0.80
36
283
(3019150) Specific gravity of Urine by Refractometry
63
664
0.94
0.15
4.4
4.1
kg/l
1.0
1.0
—
10
99
(3002179) Metamyelocytes/100 leukocytes in Blood
27
246
1.11
0.15
4.2
4.2
%
1.1
0.4
—
7
60
(40768793) Breast Pathology biopsy report
7
86
0.81
0.14
1.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
181
0.88
0.14
1.8
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
170
0.88
0.14
3.1
2.8
e6/l
0.2
0.1
0.13
15
164
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
170
0.88
0.14
1.1
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
42
394
1.07
0.13
9.5
7.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.1
—
27.3
—
0
10
(3044290) Cell count panel - Cerebral spinal fluid
6
55
1.09
0.09
1.0
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
123
0.89
0.08
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
15
137
1.10
0.07
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
84
0.83
0.07
1.1
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
86
1.05
0.07
1.4
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
89
1.13
0.07
2.7
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
132
0.91
0.06
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
100
0.90
0.06
3.0
3.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
152
0.92
0.06
1.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
90
1.11
0.05
2.7
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
367
1.04
0.05
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
308
3067
1.02
0.03
4.5
4.5
mmol/l
1.4
1.5
1.74
287
2805
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
316
3148
1.02
0.03
5.3
5.1
mmol/l
2.6
2.7
1.99
292
2873
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
152
1.05
0.02
1.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
492
1.02
0.01
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
297
2962
1.01
0.01
4.1
4.1
mmol/l
1.3
1.3
0.32
278
2695
(3022621) pH of Urine by Test strip
21
204
1.03
0.00
2.9
3.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
98
1.02
0.00
2.3
5.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
168
1.01
0.00
2.8
4.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
111
0.99
0.00
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.4
—
0
6
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
7
0.00
0.00
0.0
1.1
—
8.6
—
0
7
(3028300) Cannabinoids [Presence] in Urine
8
85
0.94
0.00
1.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
40
400
1.00
0.00
4.3
4.7
%
35.7
31.8
1.57
26
256
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
3.8
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
77
0.91
0.00
1.1
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
64
0.94
0.00
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
52
0.96
0.00
1.4
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
308
3080
1.00
0.00
4.7
4.6
mmol/l
4.5
4.6
1.83
286
2834
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
85
0.94
0.00
1.1
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
38.2
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_INTRATHORACIC and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_INTRATHORACIC 1.723 [1.35, 2.2] < 0.001
Birth year 0.99 [0.98, 1.0] 0.024

During the follow-up period (1.1.1998 — 31.12.2019), 170 out of 792 females with CD2_BENIGN_INTRATHORACIC died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_INTRATHORACIC 1.914 [1.5, 2.44] < 0.001
Birth year 0.988 [0.98, 1.0] 0.013

During the follow-up period (1.1.1998 — 31.12.2019), 144 out of 631 males with CD2_BENIGN_INTRATHORACIC died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_INTRATHORACIC.

N-year risk Females Males
1 0.14% 0.406%
5 0.988% 2.501%
10 2.339% 6.167%
15 4.24% 11.267%
20 7.286% 18.197%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_INTRATHORACIC – Benign neoplasm of other and unspecified intrathoracic organs

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data